Bachem Holding AG Bachem Holding AG

Bachem Holding AG

BANB

株式のランク #2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
株価
$100.60
時価総額
$7.54B
変化(1日)
-1.49%
変化(1年)
49.53%
国
CH
取引 Bachem Holding AG (BANB)

カテゴリー

Healthcare
Bachem Holding AG(BANB)のP/B比率
October 2026 時点のP/B比率 TTM: 4.31
Bachem Holding AG の最新の財務報告および株価によると、現在のP/B比率(TTM)は 4.31 です。2024 年末時点でのP/B比率は 3.12 でした。
Bachem Holding AG の P/B 比率の履歴(2002 ~ 2026)
各年末時点のP/B比率
年 P/B比率 変化
2026 (TTM) 4.31 40.03%
2025 3.08 -1.34%
2024 3.12 -15.11%
2023 3.68 -26.96%
2022 5.03 -44.38%
2021 9.05 -22.23%
2020 11.64 143.30%
2019 4.78 18.05%
2018 4.05 -27.47%
2017 5.59 66.84%
2016 3.35 68.44%
2015 1.99 4.79%
2014 1.90 -2.54%
2013 1.95 29.71%
2012 1.50 14.42%
2011 1.31 -37.56%
2010 2.10 -11.45%
2009 2.37 -17.55%
2008 2.88 -18.65%
2007 3.54 13.43%
2006 3.12 -76.81%
2005 13.44 424.43%
2004 2.56 2,367.37%
2003 0.10 11,444.44%
2002 0.00 0.00%
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
6.251 44.93%
US
13.2547 207.32%
US
4.4521 3.23%
AU
6.3632 47.54%
NL
- -
CH